ARTLNasdaqPharmaceutical PreparationsFiscal year ends December 31
ARTELO BIOSCIENCES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Aug 20, 2026
$2.66−0.04 (-1.48%)
Close on Oct 19, 2026
- Market cap
- $7.21M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Artelo Biosciences has not reported a dividend
No dividend per share appears in Artelo Biosciences's annual filings since fiscal 2014.